Latest News- Electroporation and Electrofusion Market: Consumables is expected to lead the Product segment during 2024-2028

The Electroporation and Electrofusion Market is being driven by Growing incidence and prevalence of cancer

The Electroporation and Electrofusion Market is expected to grow at a CAGR of 7.27% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 238.95 million. In the realm of biotechnology, biopharmaceuticals represent a significant and growing sector, encompassing a diverse range of products derived from biological sources. These include vaccines, blood components, allergenics, stem cells, tissues, gene therapies, monoclonal antibodies, and recombinant therapeutic proteins. The therapeutic applications of biopharmaceuticals extend to regenerative medicine, where stem cells are utilized to replace damaged or diseased tissues in patients afflicted by severe chronic conditions. With their capacity for indefinite division and differentiation into various tissues, stem cells hold immense promise. The recent years have witnessed a surging demand for biopharmaceutical products, particularly those derived from mammalian cells, driven by their potential to address unmet medical needs and improve patient outcomes. 

Get more information on Electroporation and Electrofusion Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Consumables
  • Systems
• End-user
  • Industrial laboratories and CROs
  • Academic and government research institutes
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Growing incidence and prevalence of cancer
• Rising demand for biologics leading to increased demand for electroporation and electrofusion
• Rising demand for monoclonal antibodies

However, the market also witnesses some limitations, which are as follows:

• High costs of instruments
• Shortage of skilled healthcare professionals
• Disruptions associated with efficiency of electroporation and electrofusion devices

Benefits of Buying Global Electroporation and Electrofusion Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Electroporation and Electrofusion Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Electroporation and Electrofusion Market encompasses technologies and devices used for enhancing the efficiency of cell transformation through electroporation and fusion via electrofusion. Key factors include optimizing electroporation and electrofusion parameters, electrode maintenance, and microfluidic control. Electrode fouling and cell death, including electroporation-induced apoptosis and electrofusion-induced cell death, are critical concerns. Pulse waveform and shape, electrode material characterization, and surface modification are essential for electrode longevity, reusability, and biocompatibility. The market includes electroporation and electrofusion devices, kits, services, and research in various applications, such as microfluidic automation and integration.

Market Research Overview

The electroporation and electrofusion market is a significant segment of the global life sciences tools and services market, which was valued at USD132.53 billion in 2023. This market encompasses companies and products involved in research and development (R&D) of cell membrane permeabilization technologies, gene and RNA delivery systems, cell transformation, tissue engineering, and drug delivery solutions. Key applications include gene editing, biopharmaceutical development, and laboratory diagnosis of various diseases. The market is expected to grow moderately during the forecast period, driven by increasing demand for advanced research tools and services in the life sciences sector.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/